Skip to content
Screener

Scholar Rock SRRK Other income, net (Note 6)

Other income, net (Note 6) at other companies

Biogen logo
BiogenBIIB
$3M+191%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$1.61M+126%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$4.42M-36.9%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$214K+3.4%
CalAmp logo
CalAmpCAMP
$18K-77.2%
Wave Life Sciences logo
Wave Life SciencesWVE
-$275K-235%

Segments

By segment

See full
Single Reportable$995K+148%

Other financials

Income statement

See full
Revenue-
Operating income-$108.9M+2.9%
Net income-$109.9M+0.1%
EPS (diluted)-$0.84+14.3%

Balance sheet

See full
Cash & equivalents$437.1M+186%
Total debt$203.8M+231%
Total equity$253.8M+8.8%
Total assets$523.5M+54.0%

Cash flow

See full
Operating cash flow-$70.3M+8.6%
CapEx$1.0K-99.5%
Free cash flow-$70.3M+8.9%

Valuation

See full
Market cap$6.41B+92.7%
Enterprise value$6.18B+90.9%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-167.8%-4.1pp
Debt / equity0.8×+0.5×
Current ratio+0.7×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Scholar Rock’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:20 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336732
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Loss on extinguishment of debt(3,337)
Interest income4,0933,4117,0287,641
Interest expense(4,518)(1,206)(6,820)(3,025)
Other expense, net(570)(127)(1,360)(171)
Total other income (expense), net(995)2,078(4,489)4,445
Net loss$$(109,896)(110,031)$(215,406)$(184,754)
Net loss per share, basic and diluted$$(0.84)(0.98)$(1.67)$(1.65)
Weighted average common shares outstanding, basic and diluted130,612,734112,703,014128,954,153112,273,032

Item 1. Financial Statements

FAQ

What is Scholar Rock's other income, net (note 6)?
Scholar Rock (SRRK) reported other income, net (note 6) of -$570K in Q2 2026.
How has Scholar Rock's other income, net (note 6) changed year-over-year?
Scholar Rock's other income, net (note 6) decreased by 348.8% year-over-year, from -$127K to -$570K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Scholar Rock's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude